Brief: Innate Pharma End-March Cash Position Of EUR 113.9 Mln

Innate Pharma SA

14/05/2024 06:12

May 14 (Reuters) - Innate Pharma SA  IPH.PA :
    * REPORTS FIRST QUARTER 2024 BUSINESS UPDATE AND FINANCIAL
RESULTS
    * CASH POSITION OF EUR 113.9 MILLION AS OF MARCH 31, 2024
(NOT
INCLUDING EUR 4.0 MILLION PAYMENT TO BE RECEIVED FROM SANOFI),
ANTICIPATED CASH RUNWAY INTO END 2025

Source text for Workspace:  ID:nBw1SycQNa 
Further company coverage:  IPH.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))